Potential role of exosomes in mending a broken heart: Nanoshuttles propelling future clinical therapeutics forward

Stem Cells International

Volumn 2017, Issue , 2017, Pages

  Dougherty, Julie A ^a   Mergaye, Muhamad ^a   Kumar, Naresh ^a   Chen, Chun An ^a   Angelos, Mark G ^a   Khan, Mahmood ^a  

^a THE OHIO STATE UNIVERSITY WEXNER MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MICRORNA; NANOPARTICLE; NANOSHUTTLE; PROTEIN; UNCLASSIFIED DRUG;

ANGIOGENESIS; CARDIAC MUSCLE; CARDIAC MUSCLE CELL; CARDIOVASCULAR DISEASE; CELL COMMUNICATION; CELL TRANSPORT; DISEASE MARKER; EXOSOME; GENE EXPRESSION REGULATION; HEART FUNCTION; HEART INFARCTION; HEART INJURY; HEART MUSCLE FIBROSIS; HEART MUSCLE ISCHEMIA; HEART TISSUE; HUMAN; NONHUMAN; PLURIPOTENT STEM CELL; REVIEW; SIGNAL TRANSDUCTION; STEM CELL TRANSPLANTATION; TISSUE REPAIR;

EID: 85042583457     PISSN: None     EISSN: 16879678     Source Type: Journal    
DOI: 10.1155/2017/5785436     Document Type: Review

References (128)

1. E. J. Benjamin, M. J. Blaha, S. E. Chiuve et al., "Heart disease and stroke statistics-2017 update: a report from the American Heart Association, " Circulation, vol. 135, no. 10, pp. e146-e603, 2017.
2. T. J. Thom, W. B. Kannel, H. Silbershatz, and R. B. D'Agostino, Cardiovascular Diseases in the United States and Prevention Approaches, V. Fuster, Ed., Hurst's the Heart, McGraw-Hill: New York, NY, 2001.
3. W. Y. Choi and K. D. Poss, "Cardiac regeneration, " Current Topics in Developmental Biology, vol. 100, pp. 319-344, 2012.
4. S. Makino, K. Fukuda, S. Miyoshi et al., "Cardiomyocytes can be generated from marrow stromal cells in vitro, " The Journal of Clinical Investigation, vol. 103, no. 5, pp. 697-705, 1999.
5. W. Xu, X. Zhang, H. Qian et al., "Mesenchymal stem cells from adult human bone marrow differentiate into a cardiomyocyte phenotype in vitro, " Experimental Biology and Medicine, vol. 229, no. 7, pp. 623-631, 2004.
6. M. F. Pittenger, A. M. Mackay, S. C. Beck et al., "Multilineage potential of adult human mesenchymal stem cells, " Science, vol. 284, no. 5411, pp. 143-147, 1999.
7. K. Takahashi and S. Yamanaka, "Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors, " Cell, vol. 126, no. 4, pp. 663-676, 2006.
8. J. Zhang, G. F. Wilson, A. G. Soerens et al., "Functional cardiomyocytes derived from human induced pluripotent stem cells, " Circulation Research, vol. 104, no. 4, pp. e30-e41, 2009.
9. W. A. Noort, M. I. Oerlemans, H. Rozemuller et al., "Human versus porcine mesenchymal stromal cells: phenotype, differentiation potential, immunomodulation and cardiac improvement after transplantation, " Journal of Cellular and Molecular Medicine, vol. 16, no. 8, pp. 1827-1839, 2012.
10. T. I. van der Spoel, K. R. Vrijsen, S. Koudstaal et al., "Transendocardial cell injection is not superior to intracoronary infusion in a porcine model of ischaemic cardiomyopathy: a study on delivery efficiency, " Journal of Cellular and Molecular Medicine, vol. 16, no. 11, pp. 2768-2776, 2012.
11. M. C. den Haan, R. W. Grauss, A. M. Smits et al., "Cardiomyogenic differentiation-independent improvement of cardiac function by human cardiomyocyte progenitor cell injection in ischaemic mouse hearts, " Journal of Cellular and Molecular Medicine, vol. 16, no. 7, pp. 1508-1521, 2012.
12. V. B. Konala, M. K. Mamidi, R. Bhonde, A. K. Das, R. Pochampally, and R. Pal, "The current landscape of the mesenchymal stromal cell secretome: a new paradigm for cell-free regeneration, " Cytotherapy, vol. 18, no. 1, pp. 13-24, 2016.
13. A. Fuster-Matanzo, F. Gessler, T. Leonardi, N. Iraci, and S. Pluchino, "Acellular approaches for regenerative medicine: on the verge of clinical trials with extracellular membrane vesicles?, " Stem Cell Research & Therapy, vol. 6, p. 227, 2015.
14. S. D. Prabhu and N. G. Frangogiannis, "The biological basis for cardiac repair after myocardial infarction: from inflammation to fibrosis, " Circulation Research, vol. 119, no. 1, pp. 91-112, 2016.
15. D. S. Choi, D. K. Kim, Y. K. Kim, and Y. S. Gho, "Proteomics of extracellular vesicles: exosomes and ectosomes, " Mass Spectrometry Reviews, vol. 34, no. 4, pp. 474-490, 2015.
16. M. Record, K. Carayon, M. Poirot, and S. Silvente-Poirot, "Exosomes as new vesicular lipid transporters involved in cell-cell communication and various pathophysiologies, " Biochimica et Biophysica Acta (BBA)-Molecular and Cell Biology of Lipids, vol. 1841, no. 1, pp. 108-120, 2014.
17. U. Gezer, E. Özgür, M. Cetinkaya, M. Isin, and N. Dalay, "Long non-coding RNAs with low expression levels in cells are enriched in secreted exosomes, " Cell Biology International, vol. 38, no. 9, pp. 1076-1079, 2014.
18. A. Ahadi, S. Brennan, P. J. Kennedy, G. Hutvagner, and N. Tran, "Long non-coding RNAs harboring miRNA seed regions are enriched in prostate cancer exosomes, " Scientific Reports, vol. 6, article 24922, 2016.
19. S. Ohno and M. Kuroda, "Exosome-mediated targeted delivery of miRNAs, " Methods in Molecular Biology, vol. 1448, pp. 261-270, 2016.
20. J. Lotvall, A. F. Hill, F. Hochberg et al., "Minimal experimental requirements for definition of extracellular vesicles and their functions: a position statement from the International Society for Extracellular Vesicles, " Journal of Extracellular Vesicles, vol. 3, article 26913, 2014.
21. C. Thery, "Exosomes: secreted vesicles and intercellular communications, " F1000 Biology Reports, vol. 3, p. 15, 2011.
22. S. EL Andaloussi, I. Mäger, X. O. Breakefield, and M. J. Wood, "Extracellular vesicles: biology and emerging therapeutic opportunities, " Nature Reviews Drug Discovery, vol. 12, no. 5, pp. 347-357, 2013.
23. K. W. Witwer, E. I. Buzás, L. T. Bemis et al., "Standardization of sample collection, isolation and analysis methods in extracellular vesicle research, " Journal of Extracellular Vesicles, vol. 2, 2013.
24. C. Thery, M. Ostrowski, and E. Segura, "Membrane vesicles as conveyors of immune responses, " Nature Reviews Immunology, vol. 9, no. 8, pp. 581-593, 2009.
25. R. M. Johnstone, M. Adam, J. R. Hammond, L. Orr, and C. Turbide, "Vesicle formation during reticulocyte maturation. Association of plasma membrane activities with released vesicles (exosomes), " The Journal of Biological Chemistry, vol. 262, no. 19, pp. 9412-9420, 1987.
26. C. Thery, M. Boussac, P. Véron et al., "Proteomic analysis of dendritic cell-derived exosomes: a secreted subcellular compartment distinct from apoptotic vesicles, " Journal of Immunology, vol. 166, no. 12, pp. 7309-7318, 2001.
27. C. Thery, A. Regnault, J. Garin et al., "Molecular characterization of dendritic cell-derived exosomes. Selective accumulation of the heat shock protein hsc73, " The Journal of Cell Biology, vol. 147, no. 3, pp. 599-610, 1999.
28. S. Mathivanan and R. J. Simpson, "ExoCarta: a compendium of exosomal proteins and RNA, " Proteomics, vol. 9, no. 21, pp. 4997-5000, 2009.
29. D. Fitzner, M. Schnaars, D. van Rossum et al., "Selective transfer of exosomes from oligodendrocytes to microglia by macropinocytosis, " Journal of Cell Science, vol. 124, Part 3, pp. 447-458, 2011.
30. T. Tian, Y. L. Zhu, Y. Y. Zhou et al., "Exosome uptake through clathrin-mediated endocytosis and macropinocytosis and mediating miR-21 delivery, " The Journal of Biological Chemistry, vol. 289, no. 32, article 24951588, pp. 22258-22267, 2014.
31. K. J. Svensson, H. C. Christianson, A. Wittrup et al., "Exosome uptake depends on ERK1/2-heat shock protein 27 signaling and lipid raft-mediated endocytosis negatively regulated by caveolin-1, " The Journal of Biological Chemistry, vol. 288, no. 24, pp. 17713-17724, 2013.
32. A. R. Soares, T. Martins-Marques, T. Ribeiro-Rodrigues et al., "Gap junctional protein Cx43 is involved in the communication between extracellular vesicles and mammalian cells, " Scientific Reports, vol. 5, article 13243, 2015
33. M. Simons and G. Raposo, "Exosomes-vesicular carriers for intercellular communication, " Current Opinion in Cell Biology, vol. 21, no. 4, pp. 575-581, 2009.
34. M. Mittelbrunn, C. Gutiérrez-Vázquez, C. Villarroya-Beltri et al., "Unidirectional transfer of microRNA-loaded exosomes from T cells to antigen-presenting cells, " Nature Communications, vol. 2, p. 282, 2011.
35. K. R. Vrijsen, J. P. Sluijter, M. W. Schuchardt et al., "Cardiomyocyte progenitor cell-derived exosomes stimulate migration of endothelial cells, " Journal of Cellular and Molecular Medicine, vol. 14, no. 5, pp. 1064-1070, 2010.
36. S. G. Ong, W. H. Lee, M. Huang et al., "Cross talk of combined gene and cell therapy in ischemic heart disease: role of exosomal microRNA transfer, " Circulation, vol. 130, no. 11, Supplement 1, pp. S60-S69, 2014.
37. B. Yu, H. W. Kim, M. Gong et al., "Exosomes secreted from GATA-4 overexpressing mesenchymal stem cells serve as a reservoir of anti-apoptotic microRNAs for cardioprotection, " International Journal of Cardiology, vol. 182, pp. 349-360, 2015.
38. M. Khan, E. Nickoloff, T. Abramova et al., "Embryonic stem cell-derived exosomes promote endogenous repair mechanisms and enhance cardiac function following myocardial infarction, " Circulation Research, vol. 117, no. 1, pp. 52-64, 2015.
39. E. Hergenreider, S. Heydt, K. Tréguer et al., "Atheroprotective communication between endothelial cells and smooth muscle cells through miRNAs, " Nature Cell Biology, vol. 14, no. 3, pp. 249-256, 2012.
40. S. Sahoo and D. W. Losordo, "Exosomes and cardiac repair after myocardial infarction, " Circulation Research, vol. 114, no. 2, pp. 333-344, 2014.
41. L. Barile, M. Gherghiceanu, L. M. Popescu, T. Moccetti, and G. Vassalli, "Ultrastructural evidence of exosome secretion by progenitor cells in adult mouse myocardium and adult human cardiospheres, " Journal of Biomedicine & Biotechnology, vol. 2012, Article ID 354605, 2012.
42. C. G. Manole, V. Cismaşiu, M. Gherghiceanu, and L. M. Popescu, "Experimental acute myocardial infarction: telocytes involvement in neo-angiogenesis, " Journal of Cellular and Molecular Medicine, vol. 15, no. 11, pp. 2284-2296, 2011.
43. J. Xiao, Y. Pan, X. H. Li et al., "Cardiac progenitor cell-derived exosomes prevent cardiomyocytes apoptosis through exosomal miR-21 by targeting PDCD4, " Cell Death & Disease, vol. 7, no. 6, article e2277, 2016.
44. A. R. Mackie, E. Klyachko, T. Thorne et al., "Sonic hedgehogmodified human CD34+ cells preserve cardiac function after acute myocardial infarction, " Circulation Research, vol. 111, no. 3, pp. 312-321, 2012.
45. S. Sahoo, E. Klychko, T. Thorne et al., "Exosomes from human CD34(+) stem cells mediate their proangiogenic paracrine activity, " Circulation Research, vol. 109, no. 7, pp. 724-728, 2011.
46. C. Lee, S. A. Mitsialis, M. Aslam et al., "Exosomes mediate the cytoprotective action of mesenchymal stromal cells on hypoxia-induced pulmonary hypertension, " Circulation, vol. 126, no. 22, pp. 2601-2611, 2012.
47. F. Arslan, R. C. Lai, M. B. Smeets et al., "Mesenchymal stem cell-derived exosomes increase ATP levels, decrease oxidative stress and activate PI3K/Akt pathway to enhance myocardial viability and prevent adverse remodeling after myocardial ischemia/reperfusion injury, " Stem Cell Research, vol. 10, no. 3, pp. 301-312, 2013.
48. R. C. Lai, F. Arslan, M. M. Lee et al., "Exosome secreted by MSC reduces myocardial ischemia/reperfusion injury, " Stem Cell Research, vol. 4, no. 3, pp. 214-222, 2010.
49. S. Bian, L. Zhang, L. Duan, X. Wang, Y. Min, and H. Yu, "Extracellular vesicles derived from human bone marrow mesenchymal stem cells promote angiogenesis in a rat myocardial infarction model, " Journal of molecular medicine, vol. 92, no. 4, pp. 387-397, 2014.
50. L. Shao, Y. Zhang, B. Lan et al., "MiRNA-sequence indicates that mesenchymal stem cells and exosomes have similar mechanism to enhance cardiac repair, " BioMed Research International, vol. 2017, Article ID 4150705, 2017.
51. Y. Feng, W. Huang, M. Wani, X. Yu, and M. Ashraf, "Ischemic preconditioning potentiates the protective effect of stem cells through secretion of exosomes by targeting Mecp2 via miR-22, " PLoS One, vol. 9, no. 2, article e88685, 2014.
52. Z. Giricz, Z. V. Varga, T. Baranyai et al., "Cardioprotection by remote ischemic preconditioning of the rat heart is mediated by extracellular vesicles, " Journal of Molecular and Cellular Cardiology, vol. 68, pp. 75-78, 2014.
53. P. van Vliet, M. Roccio, A. M. Smits et al., "Progenitor cells isolated from the human heart: a potential cell source for regenerative therapy, " Netherlands Heart Journal, vol. 16, no. 5, pp. 163-169, 2008.
54. A. M. Smits, L. W. van Laake, K. den Ouden et al., "Human cardiomyocyte progenitor cell transplantation preserves long-term function of the infarcted mouse myocardium, " Cardiovascular Research, vol. 83, no. 3, pp. 527-535, 2009.
55. L. Barile, V. Lionetti, E. Cervio et al., "Extracellular vesicles from human cardiac progenitor cells inhibit cardiomyocyte apoptosis and improve cardiac function after myocardial infarction, " Cardiovascular Research, vol. 103, no. 4, pp. 530-541, 2014.
56. L. Cambier, G. de Couto, A. Ibrahim et al., "Y RNA fragment in extracellular vesicles confers cardioprotection via modulation of IL-10 expression and secretion, " EMBO Molecular Medicine, vol. 9, no. 3, pp. 337-352, 2017.
57. T. H. Adair and J. P. Montani, Angiogenesis. San Rafael (CA), 2010.
58. J. D. Anderson, H. J. Johansson, C. S. Graham et al., "Comprehensive proteomic analysis of mesenchymal stem cell exosomes reveals modulation of angiogenesis via nuclear factor-KappaB signaling, " Stem Cells, vol. 34, no. 3, pp. 601-613, 2016.
59. C. Beltrami, M. Besnier, S. Shantikumar et al., "Human pericardial fluid contains exosomes enriched with cardiovascular-expressed microRNAs and promotes therapeutic angiogenesis, " Molecular Therapy, vol. 25, no. 3, pp. 679-693, 2017.
60. W. Du, K. Zhang, S. Zhang et al., "Enhanced proangiogenic potential of mesenchymal stem cell-derived exosomes stimulated by a nitric oxide releasing polymer, " Biomaterials, vol. 133, pp. 70-81, 2017.
61. M. Gong, B. Yu, J. Wang et al., "Mesenchymal stem cells release exosomes that transfer miRNAs to endothelial cells and promote angiogenesis, " Oncotarget, vol. 8, no. 28, pp. 45200-45212, 2017.
62. H. Gonzalez-King, N. A. García, I. Ontoria-Oviedo, M. Ciria, J. A. Montero, and P. Sepúlveda, "Hypoxia inducible factor-1alpha potentiates jagged 1-mediated angiogenesis by mesenchymal stem cell-derived exosomes, " Stem Cells, vol. 35, no. 7, pp. 1747-1759, 2017.
63. K. Kang, R. Ma, W. Cai et al., "Exosomes secreted from CXCR4 overexpressing mesenchymal stem cells promote cardioprotection via Akt signaling pathway following myocardial infarction, " Stem Cells International, vol. 2015, Article ID 659890, 2015.
64. J. Ma, Y. Zhao, L. Sun et al., "Exosomes derived from Aktmodified human umbilical cord mesenchymal stem cells improve cardiac regeneration and promote angiogenesis via activating platelet-derived growth factor D, " Stem Cells Translational Medicine, vol. 6, no. 1, pp. 51-59, 2017.
65. P. Mathiyalagan, Y. Liang, D. Kim et al., "Angiogenic mechanisms of human CD34+ stem cell exosomes in the repair of ischemic hindlimb, " Circulation Research, 2017.
66. X. Teng, L. Chen, W. Chen, J. Yang, Z. Yang, and Z. Shen, "Mesenchymal stem cell-derived exosomes improve the microenvironment of infarcted myocardium contributing to angiogenesis and anti-inflammation, " Cellular Physiology and Biochemistry, vol. 37, no. 6, pp. 2415-2424, 2015.
67. Z. Zhang, J. Yang, W. Yan, Y. Li, Z. Shen, and T. Asahara, "Pretreatment of cardiac stem cells with exosomes derived from mesenchymal stem cells enhances myocardial repair, " Journal of the American Heart Association, vol. 5, no. 1, 2016.
68. Y. Zhao, X. Sun, W. Cao et al., "Exosomes derived from human umbilical cord mesenchymal stem cells relieve acute myocardial ischemic injury, " Stem Cells International, vol. 2015, Article ID 761643, 2015.
69. A. Barajas-Espinosa, A. Basye, M. G. Angelos, and C. A. Chen, "Modulation of p38 kinase by DUSP4 is important in regulating cardiovascular function under oxidative stress, " Free Radical Biology & Medicine, vol. 89, pp. 170-181, 2015.
70. A. Barajas-Espinosa, A. Basye, E. Jesse, H. Yan, D. Quan, and C. A. Chen, "Redox activation of DUSP4 by N-acetylcysteine protects endothelial cells from Cd(2)(+)-induced apoptosis, " Free Radical Biology & Medicine, vol. 74, pp. 188-199, 2014.
71. J. A. Dougherty, J. Kilbane Myers, M. Khan, M. G. Angelos, and C. A. Chen, "Dual-specificity phosphatase 4 overexpression in cells prevents hypoxia/reoxygenation-induced apoptosis via the upregulation of eNOS, " Frontiers in Cardiovascular Medicine, vol. 4, p. 22, 2017.
72. D. P. Bartel, "MicroRNAs: genomics, biogenesis, mechanism, and function, " Cell, vol. 116, no. 2, pp. 281-297, 2004.
73. V. Ambros, "The functions of animal microRNAs, " Nature, vol. 431, no. 7006, pp. 350-355, 2004.
74. H. Valadi, K. Ekström, A. Bossios, M. Sjöstrand, J. J. Lee, and J. O. Lötvall, "Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells, " Nature Cell Biology, vol. 9, no. 6, pp. 654-659, 2007.
75. J. Skog, T. Würdinger, S. van Rijn et al., "Glioblastoma microvesicles transport RNA and proteins that promote tumour growth and provide diagnostic biomarkers, " Nature Cell Biology, vol. 10, no. 12, pp. 1470-1476, 2008.
76. J. Guduric-Fuchs, A. O'Connor, B. Camp, C. L. O'Neill, R. J. Medina, and D. A. Simpson, "Selective extracellular vesiclemediated export of an overlapping set of microRNAs from multiple cell types, " BMC Genomics, vol. 13, p. 357, 2012.
77. M. L. Squadrito, C. Baer, F. Burdet et al., "Endogenous RNAs modulate microRNA sorting to exosomes and transfer to acceptor cells, " Cell Reports, vol. 8, no. 5, pp. 1432-1446, 2014.
78. S. Siddiqi, N. Gude, T. Hosoda et al., "Myocardial induction of nucleostemin in response to postnatal growth and pathological challenge, " Circulation Research, vol. 103, no. 1, pp. 89-97, 2008.
79. S. A. Hanina, W. Mifsud, T. A. Down et al., "Genome-wide identification of targets and function of individual Micro-RNAs in mouse embryonic stem cells, " PLoS Genetics, vol. 6, no. 10, article e1001163, 2010.
80. Y. Lin, X. Liu, Y. Cheng, J. Yang, Y. Huo, and C. Zhang, "Involvement of microRNAs in hydrogen peroxidemediated gene regulation and cellular injury response in vascular smooth muscle cells, " The Journal of Biological Chemistry, vol. 284, no. 12, pp. 7903-7913, 2009.
81. U. Liwak-Muir, C. C. Dobson, T. Naing et al., "ERK8 is a novel HuR kinase that regulates tumour suppressor PDCD4 through a miR-21 dependent mechanism, " Oncotarget, vol. 7, no. 2, pp. 1439-1450, 2016.
82. L. Chen, Y. Wang, Y. Pan et al., "Cardiac progenitor-derived exosomes protect ischemic myocardium from acute ischemia/ reperfusion injury, " Biochemical and Biophysical Research Communications, vol. 431, no. 3, pp. 566-571, 2013.
83. X. Zhang, X. Wang, H. Zhu et al., "Synergistic effects of the GATA-4-mediated miR-144/451 cluster in protection against simulated ischemia/reperfusion-induced cardiomyocyte death, " Journal of Molecular and Cellular Cardiology, vol. 49, no. 5, pp. 841-850, 2010.
84. Y. Q. Yang, L. Gharibeh, R. G. Li et al., "GATA4 loss-offunction mutations underlie familial tetralogy of fallot, " Human Mutation, vol. 34, no. 12, pp. 1662-1671, 2013.
85. Y. S. Ang, R. N. Rivas, A. J. Ribeiro et al., "Disease model of GATA4 mutation reveals transcription factor cooperativity in human cardiogenesis, " Cell, vol. 167, no. 7, pp. 1734-1749 e22, 2016.
86. Y. Liang, D. Ridzon, L. Wong, and C. Chen, "Characterization of microRNA expression profiles in normal human tissues, " BMC Genomics, vol. 8, p. 166, 2007.
87. A. Izarra, I. Moscoso, E. Levent et al., "miR-133a enhances the protective capacity of cardiac progenitors cells after myocardial infarction, " Stem Cell Reports, vol. 3, no. 6, pp. 1029-1042, 2014.
88. U. Agarwal, A. George, S. Bhutani et al., "Experimental, systems, and computational approaches to understanding the microRNA-mediated reparative potential of cardiac progenitor cell-derived exosomes from pediatric patients, " Circulation Research, vol. 120, no. 4, pp. 701-712, 2017.
89. M. Khan, Y. Xu, S. Hua et al., "Correction: evaluation of changes in morphology and function of human induced pluripotent stem cell derived cardiomyocytes (HiPSC-CMs) cultured on an aligned-nanofiber cardiac patch, " PLoS One, vol. 10, no. 10, article e0141176, 2015.
90. L. Citro, S. Naidu, F. Hassan et al., "Comparison of human induced pluripotent stem-cell derived cardiomyocytes with human mesenchymal stem cells following acute myocardial infarction, " PLoS One, vol. 9, no. 12, article e116281, 2014.
91. F. Jansen, X. Yang, S. Proebsting et al., "MicroRNA expression in circulating microvesicles predicts cardiovascular events in patients with coronary artery disease, " Journal of the American Heart Association, vol. 3, no. 6, article e001249, 2014.
92. P. Jakob, C. Doerries, S. Briand et al., "Loss of angiomiR-126 and 130a in angiogenic early outgrowth cells from patients with chronic heart failure: role for impaired in vivo neovascularization and cardiac repair capacity, " Circulation, vol. 126, no. 25, pp. 2962-2975, 2012.
93. J. E. Fish, M. M. Santoro, S. U. Morton et al., "miR-126 regulates angiogenic signaling and vascular integrity, " Developmental Cell, vol. 15, no. 2, pp. 272-284, 2008.
94. S. Rane, M. He, D. Sayed et al., "Downregulation of miR-199a derepresses hypoxia-inducible factor-1alpha and sirtuin 1 and recapitulates hypoxia preconditioning in cardiac myocytes, " Circulation Research, vol. 104, no. 7, pp. 879-886, 2009.
95. J. Liu, Y. Wang, J. Cui et al., "miR199a-3p regulates P53 by targeting CABLES1 in mouse cardiac c-kit+ cells to promote proliferation and inhibit apoptosis through a negative feedback loop, " Stem Cell Research & Therapy, vol. 8, no. 1, p. 127, 2017.
96. Y. Kuwabara, K. Ono, T. Horie et al., "Increased microRNA-1 and microRNA-133a levels in serum of patients with cardiovascular disease indicate myocardial damage, " Circulation. Cardiovascular Genetics, vol. 4, no. 4, pp. 446-454, 2011.
97. Y. Yang, Y. Li, X. Chen, X. Cheng, Y. Liao, and X. Yu, "Exosomal transfer of miR-30a between cardiomyocytes regulates autophagy after hypoxia, " Journal of Molecular Medicine, vol. 94, no. 6, pp. 711-724, 2016.
98. S. Matsumoto, Y. Sakata, S. Suna et al., "Circulating p53-responsive microRNAs are predictive indicators of heart failure after acute myocardial infarction, " Circulation Research, vol. 113, no. 3, pp. 322-326, 2013.
99. T. C. Chang, E. A. Wentzel, O. A. Kent et al., "Transactivation of miR-34a by p53 broadly influences gene expression and promotes apoptosis, " Molecular Cell, vol. 26, no. 5, pp. 745-752, 2007.
100. F. Pichiorri, S. S. Suh, A. Rocci et al., "Downregulation of p53-inducible microRNAs 192, 194, and 215 impairs the p53/MDM2 autoregulatory loop in multiple myeloma development, " Cancer Cell, vol. 18, no. 4, pp. 367-381, 2010.
101. A. Brill, O. Dashevsky, J. Rivo, Y. Gozal, and D. Varon, "Platelet-derived microparticles induce angiogenesis and stimulate post-ischemic revascularization, " Cardiovascular Research, vol. 67, no. 1, pp. 30-38, 2005.
102. J. M. Vicencio, D. M. Yellon, V. Sivaraman et al., "Plasma exosomes protect the myocardium from ischemiareperfusion injury, " Journal of the American College of Cardiology, vol. 65, no. 15, pp. 1525-1536, 2015.
103. L. Alvarez-Erviti, Y. Seow, H. Yin, C. Betts, S. Lakhal, and M. J. Wood, "Delivery of siRNA to the mouse brain by systemic injection of targeted exosomes, " Nature Biotechnology, vol. 29, no. 4, pp. 341-345, 2011.
104. M. J. Cooke, M. Stojkovic, and S. A. Przyborski, "Growth of teratomas derived from human pluripotent stem cells is influenced by the graft site, " Stem Cells and Development, vol. 15, no. 2, pp. 254-259, 2006.
105. J. L. Fox, "FDA scrutinizes human stem cell therapies, " Nature Biotechnology, vol. 26, no. 6, pp. 598-599, 2008.
106. J. A. Heslop, T. G. Hammond, I. Santeramo et al., "Concise review: workshop review: understanding and assessing the risks of stem cell-based therapies, " Stem Cells Translational Medicine, vol. 4, no. 4, pp. 389-400, 2015.
107. A. S. Lee, C. Tang, M. S. Rao, I. L. Weissman, and J. C. Wu, "Tumorigenicity as a clinical hurdle for pluripotent stem cell therapies, " Nature Medicine, vol. 19, no. 8, pp. 998-1004, 2013.
108. T. Fujikawa, S. H. Oh, L. Pi, H. M. Hatch, T. Shupe, and B. E. Petersen, "Teratoma formation leads to failure of treatment for type I diabetes using embryonic stem cell-derived insulin-producing cells, " The American Journal of Pathology, vol. 166, no. 6, pp. 1781-1791, 2005.
109. N. Amariglio, A. Hirshberg, B. W. Scheithauer et al., "Donorderived brain tumor following neural stem cell transplantation in an ataxia telangiectasia patient, " PLoS Medicine, vol. 6, no. 2, article e1000029, 2009.
110. B. J. Dlouhy, O. Awe, R. C. Rao, P. A. Kirby, and P. W. Hitchon, "Autograft-derived spinal cord mass following olfactory mucosal cell transplantation in a spinal cord injury patient: case report, " Journal of Neurosurgery Spine, vol. 21, no. 4, pp. 618-622, 2014.
111. C. P. Lai, E. Y. Kim, C. E. Badr et al., "Visualization and tracking of tumour extracellular vesicle delivery and RNA translation using multiplexed reporters, " Nature Communications, vol. 6, p. 7029, 2015.
112. C. P. Lai, O. Mardini, M. Ericsson et al., "Dynamic biodistribution of extracellular vesicles in vivo using a multimodal imaging reporter, " ACS Nano, vol. 8, no. 1, pp. 483-494, 2014.
113. J. A. Bradley, E. M. Bolton, and R. A. Pedersen, "Stem cell medicine encounters the immune system, " Nature Reviews Immunology, vol. 2, no. 11, pp. 859-871, 2002.
114. X. Zhu, M. Badawi, S. Pomeroy et al., "Comprehensive toxicity and immunogenicity studies reveal minimal effects in mice following sustained dosing of extracellular vesicles derived from HEK293T cells, " Journal of Extracellular Vesicles, vol. 6, no. 1, article 1324730, 2017.
115. B. Escudier, T. Dorval, N. Chaput et al., "Vaccination of metastatic melanoma patients with autologous dendritic cell (DC) derived-exosomes: results of the first phase I clinical trial, " Journal of Translational Medicine, vol. 3, no. 1, p. 10, 2005.
116. M. A. Morse, J. Garst, T. Osada et al., "A phase I study of dexosome immunotherapy in patients with advanced nonsmall cell lung cancer, " Journal of Translational Medicine, vol. 3, no. 1, p. 9, 2005.
117. S. Dai, D. Wei, Z. Wu et al., "Phase I clinical trial of autologous ascites-derived exosomes combined with GM-CSF for colorectal cancer, " Molecular Therapy, vol. 16, no. 4, pp. 782-790, 2008.
118. M. Gyongyosi, J. Blanco, T. Marian et al., "Serial noninvasive in vivo positron emission tomographic tracking of percutaneously intramyocardially injected autologous porcine mesenchymal stem cells modified for transgene reporter gene expression, " Circulation. Cardiovascular Imaging, vol. 1, no. 2, pp. 94-103, 2008.
119. A. Abdel-Latif, R. Bolli, I. M. Tleyjeh et al., "Adult bone marrow-derived cells for cardiac repair: a systematic review and meta-analysis, " Archives of Internal Medicine, vol. 167, no. 10, pp. 989-997, 2007.
120. E. Martin-Rendon, S. J. Brunskill, C. J. Hyde, S. J. Stanworth, A. Mathur, and S. M. Watt, "Autologous bone marrow stem cells to treat acute myocardial infarction: a systematic review, " European Heart Journal, vol. 29, no. 15, pp. 1807-1818, 2008.
121. M. J. Lipinski, G. G. Biondi-Zoccai, A. Abbate et al., "Impact of intracoronary cell therapy on left ventricular function in the setting of acute myocardial infarction: a collaborative systematic review and meta-analysis of controlled clinical trials, " Journal of the American College of Cardiology, vol. 50, no. 18, pp. 1761-1767, 2007.
122. K. Lunde, S. Solheim, S. Aakhus et al., "Intracoronary injection of mononuclear bone marrow cells in acute myocardial infarction, " The New England Journal of Medicine, vol. 355, no. 12, pp. 1199-1209, 2006.
123. S. Janssens, C. Dubois, J. Bogaert et al., "Autologous bone marrow-derived stem-cell transfer in patients with STsegment elevation myocardial infarction: double-blind, randomised controlled trial, " The Lancet, vol. 367, no. 9505, pp. 113-121, 2006.
124. R. Szatanek, J. Baran, M. Siedlar, and M. Baj-Krzyworzeka, "Isolation of extracellular vesicles: determining the correct approach (review), " International Journal of Molecular Medicine, vol. 36, no. 1, pp. 11-17, 2015.
125. M. E. Marcus and J. N. Leonard, "FedExosomes: engineering therapeutic biological nanoparticles that truly deliver, " Pharmaceuticals (Basel), vol. 6, no. 5, pp. 659-680, 2013.
126. R. Gallet, J. Dawkins, J. Valle et al., "Exosomes secreted by cardiosphere-derived cells reduce scarring, attenuate adverse remodelling, and improve function in acute and chronic porcine myocardial infarction, " European Heart Journal, 2016.
127. A. G. Ibrahim, K. Cheng, and E. Marban, "Exosomes as critical agents of cardiac regeneration triggered by cell therapy, " Stem Cell Reports, vol. 2, no. 5, pp. 606-619, 2014.
128. J. Halkein, S. P. Tabruyn, M. Ricke-Hoch et al., "MicroRNA-146a is a therapeutic target and biomarker for peripartum cardiomyopathy, " The Journal of Clinical Investigation, vol. 123, no. 5, pp. 2143-2154, 2013.